Brazil
· Delayed Price · Currency is BRL Dexco Statistics
Total Valuation
Dexco has a market cap or net worth of BRL 6.11 billion. The enterprise value is 11.98 billion.
| Market Cap | 6.11B |
| Enterprise Value | 11.98B |
Important Dates
The last earnings date was Wednesday, November 6, 2024.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Dexco has 808.36 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 808.36M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 20.71% |
| Owned by Institutions (%) | 22.06% |
| Float | 306.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.33 |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 61.66 |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.93 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.30, with an EV/FCF ratio of 120.86.
| EV / Earnings | 35.56 |
| EV / Sales | 1.48 |
| EV / EBITDA | 5.30 |
| EV / EBIT | 12.03 |
| EV / FCF | 120.86 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 1.17.
| Current Ratio | 1.49 |
| Quick Ratio | 1.10 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | 3.65 |
| Debt / FCF | 79.70 |
| Interest Coverage | 0.89 |
Financial Efficiency
Return on equity (ROE) is 5.25% and return on invested capital (ROIC) is 4.00%.
| Return on Equity (ROE) | 5.25% |
| Return on Assets (ROA) | 3.20% |
| Return on Capital (ROIC) | 4.00% |
| Revenue Per Employee | 570,647 |
| Profits Per Employee | 23,673 |
| Employee Count | 14,228 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 3.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.51% in the last 52 weeks. The beta is 0.90, so Dexco's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +2.51% |
| 50-Day Moving Average | 8.13 |
| 200-Day Moving Average | 7.64 |
| Relative Strength Index (RSI) | 38.70 |
| Average Volume (20 Days) | 3,104,105 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexco had revenue of BRL 8.12 billion and earned 336.82 million in profits.
| Revenue | 8.12B |
| Gross Profit | 2.41B |
| Operating Income | 898.27M |
| Pretax Income | 406.93M |
| Net Income | 336.82M |
| EBITDA | 2.06B |
| EBIT | 898.27M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 2.15 billion in cash and 7.90 billion in debt, giving a net cash position of -5.75 billion or -7.11 per share.
| Cash & Cash Equivalents | 2.15B |
| Total Debt | 7.90B |
| Net Cash | -5.75B |
| Net Cash Per Share | -7.11 |
| Equity (Book Value) | 6.73B |
| Book Value Per Share | n/a |
| Working Capital | 1.80B |
Cash Flow
In the last 12 months, operating cash flow was 1.48 billion and capital expenditures -1.38 billion, giving a free cash flow of 99.11 million.
| Operating Cash Flow | 1.48B |
| Capital Expenditures | -1.38B |
| Free Cash Flow | 99.11M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 29.63%, with operating and profit margins of 11.06% and 4.15%.
| Gross Margin | 29.63% |
| Operating Margin | 11.06% |
| Pretax Margin | 5.01% |
| Profit Margin | 4.15% |
| EBITDA Margin | 25.43% |
| EBIT Margin | 11.06% |
| FCF Margin | 1.22% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 2.93%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 2.93% |
| Dividend Growth (YoY) | -2.89% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.02% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.93% |
| Earnings Yield | n/a |
| FCF Yield | 1.62% |
Stock Splits
The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.
| Last Split Date | Dec 21, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |